Xolegel (ketoconazole, 2%).
Scheinfeld
Noah S
NS
St. Luke's-Roosevelt Hospital Center, New York, NY, USA.
D012628:Dermatitis, Seborrheic / Q000188:drug therapy*; D006801:Humans; D007654:Ketoconazole / Q000627:therapeutic use*
D007654:Ketoconazole